Our blog features educational information and personal perspectives relevant to the hereditary cancer community.
August 17, 2017
Working with Industry to Increase Patient Engagement in Drug Development
Posted in:
Research
Tags:
Hereditary Cancer Research ,
Patient Advocacy ,
Patient-centered Outcomes ,
Patient Engagement ,
Cancer Research ,
Precision Medicine
April 12, 2018
PARP Inhibitors and Hereditary Cancer: What’s New?
Posted in:
Research ,
Cancer Treatment
Tags:
BRCA ,
Ovarian Cancer ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
PALB2 ,
Pancreatic Cancer ,
ATM ,
Gene Panel Testing ,
Metastatic Breast Cancer ,
Ovarian Cancer Treatment ,
PARP Inhibitor ,
Cancer Research ,
Advanced Breast Cancer ,
Inherited Mutations ,
Prostate Cancer Treatment ,
Metastatic Prostate Cancer ,
Cancer Targeted Therapy
February 07, 2018
Why I Chose Immunotherapy for Pancreatic Cancer
Posted in:
Men With Mutations ,
Cancer Treatment
Tags:
BRCA2 ,
HBOC ,
Pancreatic Cancer ,
Cancer Research ,
Immunotherapy ,
Immunooncology ,
Pancreatic Cancer Treatment
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.
August 27, 2018
FORCE Co-Authors Paper on Engaging Patient Advocates in Research
Posted in:
Research
Tags:
Clinical Trials ,
Patient Advocacy ,
Patient Engagement ,
Cancer Research ,
Research Advocacy ,
Patient Centered Research
May 21, 2020
Clinical Trials are Essential for Improving Healthcare
Posted in:
Research ,
XRAY
Tags:
Hereditary Cancer ,
Breast Cancer ,
Ovarian Cancer ,
HBOC ,
Clinical Trials ,
Cancer Research ,
Research
May 01, 2019
Where’s FORCE?
Posted in:
FORCE And FORCE Impact
Tags:
Hereditary Cancer, Cancer Advocacy, Cancer Research, Where's Force
November 19, 2019
FORCE Launches the New XRAY-Ovarian Cancer Program
Posted in:
XRAY
Tags:
Hereditary Cancer, Ovarian Cancer, PARP Inhibitor, Cancer Research